[Are the hormones of youth carcinogenic?]

Annales D'Endocrinologie
|January 1, 2000
PubMed

Insights

Hormone decline in aging may impair physical and mental functions. Lowering hormone levels might protect against hormone-sensitive cancers, but hormone replacement therapy could increase cancer risk.

Area of Science:

  • Endocrinology
  • Gerontology
  • Oncology

Context:

  • Aging is associated with a decline in various hormones, including testosterone (T), growth hormone (GH), and dehydroepiandrosterone sulfate (DHEAS).
  • Hormone replacement therapies (HRT) like T, GH, and estrogen show benefits in elderly individuals, such as increased muscle mass and decreased cardiovascular mortality.
  • However, HRT with T and DHEA carries risks, including potential induction of prostate cancer, and estrogen therapy may increase breast cancer risk.

Purpose:

  • To explore the role of hormone decline in aging-related functional decline.
  • To investigate the potential protective effect of decreased hormone levels against hormone-sensitive cancers.
  • To examine the carcinogenic risks associated with hormone replacement therapies.

Summary:

  • Aging leads to decreased levels of hormones like testosterone, growth hormone, and DHEAS, potentially affecting physical and mental functions.
  • While hormone therapies can improve certain aspects of aging, they also present risks, such as increased cancer incidence.
  • A hypothesis suggests that reduced hormone levels during aging may offer partial protection against hormone-sensitive cancers, and hormone administration could elevate this risk.

Impact:

  • Understanding the complex relationship between aging, hormones, and cancer risk is crucial for developing safer therapeutic strategies.
  • This research highlights the need for careful consideration of potential carcinogenic risks when administering hormone therapies to the elderly.
  • Further investigation is warranted to balance the benefits of hormone replacement with the potential increase in cancer risk.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
Major Hormones and Their Functions01:27

Major Hormones and Their Functions

Hormones, the biochemical messengers produced by endocrine glands, are pivotal in regulating bodily functions and maintaining homeostasis. Each hormone's balance is crucial; imbalances can lead to significant physiological disruptions. Major hormones include oxytocin, cortisol, epinephrine, estrogen, testosterone, thyroxine, growth hormone, insulin, and glucagon.
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and lactation.